The use of renin–angiotensin–aldosterone system (RAAS) inhibitors is associated with a lower risk of mortality in hypertensive COVID‐19 patients: a systematic review …
Y Wang, B Chen, Y Li, L Zhang, Y Wang… - Journal of medical …, 2021 - Wiley Online Library
Renin–angiotensin–aldosterone system (RAAS) inhibitors, including angiotensin‐converting
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are one of the most …
enzyme inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) are one of the most …
Renin‐angiotensin aldosterone system inhibitors and COVID‐19: a systematic review and meta‐analysis revealing critical bias across a body of observational …
J Loader, FC Taylor, E Lampa… - Journal of the American …, 2022 - Am Heart Assoc
Background Renin‐angiotensin aldosterone system (RAAS) inhibitor—COVID‐19 studies,
observational in design, appear to use biased methods that can distort the interaction …
observational in design, appear to use biased methods that can distort the interaction …
Mortality and severity in COVID-19 patients on ACEIs and ARBs—a systematic review, meta-analysis, and meta-regression analysis
Purpose: The primary objective of this systematic review is to assess association of mortality
in COVID-19 patients on Angiotensin-converting-enzyme inhibitors (ACEIs) and Angiotensin …
in COVID-19 patients on Angiotensin-converting-enzyme inhibitors (ACEIs) and Angiotensin …
Effects of renin‐angiotensin‐aldosterone system inhibitors on disease severity and mortality in patients with COVID‐19: A meta‐analysis
G Zhang, Y Wu, R Xu, X Du - Journal of medical virology, 2021 - Wiley Online Library
To investigate the effects of renin‐angiotensin‐aldosterone system (RAAS) inhibitors on the
prognosis in patients with coronavirus disease 2019 (COVID‐19). A meta‐analysis was …
prognosis in patients with coronavirus disease 2019 (COVID‐19). A meta‐analysis was …
Clinical characteristics and outcome of Covid-19 illness and predictors of in-hospital mortality in Saudi Arabia
MA Abolfotouh, A Musattat, M Alanazi, S Alghnam… - BMC Infectious …, 2022 - Springer
Background Patients' race and ethnicity may play a role in mortality from Covid-19. Studies
in China, the US, and Europe have been conducted on the predictors of Covid-19 mortality …
in China, the US, and Europe have been conducted on the predictors of Covid-19 mortality …
[HTML][HTML] Angiotensin receptor blockers and angiotensin-converting enzyme inhibitors in COVID-19: meta-analysis/meta-regression adjusted for confounding factors
Abstract Background Angiotensin receptor blockers (ARBs) and/or angiotensin-converting
enzyme (ACE) inhibitors could alter mortality from coronavirus disease 2019 (COVID-19) …
enzyme (ACE) inhibitors could alter mortality from coronavirus disease 2019 (COVID-19) …
[HTML][HTML] How stable ischemic heart disease leads to acute coronary syndrome in COVID-19?
M Shafeghat, A Aminorroaya… - Acta Bio Medica: Atenei …, 2021 - ncbi.nlm.nih.gov
Since the beginning of the coronavirus disease 2019 (COVID-19) pandemic, the increased
mortality risk of patients with underlying cardiovascular diseases and COVID-19 was raised …
mortality risk of patients with underlying cardiovascular diseases and COVID-19 was raised …
Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis
Á Aparisi, P Catalá, IJ Amat-Santos, M Marcos-Mangas… - Medicina Clínica, 2022 - Elsevier
Background Hypertension is a prevalent condition among SARS-CoV-2 infected patients.
Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful …
Whether renin–angiotensin–aldosterone system (RAAS) inhibitors are beneficial or harmful …
[HTML][HTML] Renin-Angiotensin-Aldosterone system inhibitors in COVID-19: a review
F Ferrari, VM Martins, FD Fuchs, R Stein - Clinics, 2021 - SciELO Brasil
Among the multiple uncertainties surrounding the novel coronavirus disease (COVID-19)
pandemic, a research letter published in The Lancet implicated drugs that antagonize the …
pandemic, a research letter published in The Lancet implicated drugs that antagonize the …
Renin‐angiotensin aldosterone system inhibitors in primary prevention and COVID‐19
Background Considering the widespread risk of collider bias and confounding by indication
in previous research, the associations between renin‐angiotensin aldosterone system …
in previous research, the associations between renin‐angiotensin aldosterone system …